Dr Stephen Luen is an early-career Medical Oncologist and translational researcher at the Peter MacCallum Cancer Centre specialising in breast cancer, sarcoma, early drug development, and precision oncology.

In 2021, he completed a PhD supervised by Professor Sherene Loi investigating genomic and immune biomarkers in early-stage breast cancers and continues to work closely with the laboratory.

His current research interests include the study of genomic and immune biomarkers in high-risk and treatment-refractory breast cancers, the development of novel clinical trial approaches for high-risk breast cancers, and the early phase development of new therapeutic compounds.